Application of fibrin in tissue engineering. Achievements and perspectives

[1]Ahmad E., Fatima M.T., Hoque M., Owais M., Saleemuddin M.: Fibrin matrices: The versatile therapeutic delivery systems. Int. J. Biol. Macromol., 2015; 81: 121-136 Ahmad E. Fatima M.T. Hoque M. Owais M. Saleemuddin M. Fibrin matrices: The versatile therapeutic delivery systems Int. J. Biol. Macromol 2015 81 121 13610.1016/j.ijbiomac.2015.07.05426231328Search in Google Scholar

[2]Ahn J., Kim S.A., Kim K.W., Oh J.H., Kim S.J.: Optimization of TGF-β1-transduced chondrocytes for cartilage regeneration in a 3D printed knee joint model. PLoS One, 2019; 14: e0217601 Ahn J. Kim S.A. Kim K.W. Oh J.H. Kim S.J. Optimization of TGF-β1-transduced chondrocytes for cartilage regeneration in a 3D printed knee joint model PLoS One 2019 14 e021760110.1371/journal.pone.0217601653293831120999Search in Google Scholar

[3]Akpalo E., Bidault L., Boissière M., Vancaeyzeele C., Fichet O., Garde V.: Fibrin-polyethylene oxide interpenetrating polymer networks: new self-supported biomaterials combining the properties of both protein gel and synthetic polymer. Acta Biomater., 2011; 7: 2418-2427 Akpalo E. Bidault L. Boissière M. Vancaeyzeele C. Fichet O. Garde V. Fibrin-polyethylene oxide interpenetrating polymer networks: new self-supported biomaterials combining the properties of both protein gel and synthetic polymer Acta Biomater 2011 7 2418 242710.1016/j.actbio.2011.03.00221382527Search in Google Scholar

[4]Arrighi I., Mark S., Alvisi M., von Rechenberg B., Hubbell J.A., Schense J.C.: Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials, 2009; 30: 1763-1771 Arrighi I. Mark S. Alvisi M. von Rechenberg B. Hubbell J.A. Schense J.C. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug Biomaterials 2009 30 1763 177110.1016/j.biomaterials.2008.12.02319124152Search in Google Scholar

[5]Bacakova M., Musilkova J., Riedel T., Stranska D., Brynda E., Bacakova L., Zaloudkova M.: The potential applications of fibrincoated electrospun polylactide nanofibers in skin tissue engineering. Int. J. Nanomedicine, 2016; 11: 771-789 Bacakova M. Musilkova J. Riedel T. Stranska D. Brynda E. Bacakova L. Zaloudkova M. The potential applications of fibrincoated electrospun polylactide nanofibers in skin tissue engineering Int. J. Nanomedicine 2016 11 771 78910.2147/IJN.S99317477294426955273Search in Google Scholar

[6]Brown A.C., Barker T.H.: Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level. Acta Biomater., 2014; 10: 1502-1514 Brown A.C. Barker T.H. Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level Acta Biomater 2014 10 1502 151410.1016/j.actbio.2013.09.008396032424056097Search in Google Scholar

[7]Bujoli B., Scimeca J.: Fibrin as a multipurpose physiological platform for bone tissue engineering and targeted delivery of bioactive compounds. Pharmaceutics, 2019; 11: 1-15 Bujoli B. Scimeca J. Fibrin as a multipurpose physiological platform for bone tissue engineering and targeted delivery of bioactive compounds Pharmaceutics 2019 11 1 1510.3390/pharmaceutics11110556692082831661853Search in Google Scholar

[8]Cha D.M., Kim K.H., Choi H.J., Kim M.K., Wee W.R.: A comparative study of the effect of fibrin glue versus sutures on clinical outcome in patients undergoing pterygium excision and conjunctival autografts. Korean J. Ophthalmol., 2012; 26: 407-413 Cha D.M. Kim K.H. Choi H.J. Kim M.K. Wee W.R. A comparative study of the effect of fibrin glue versus sutures on clinical outcome in patients undergoing pterygium excision and conjunctival autografts Korean J. Ophthalmol 2012 26 407 41310.3341/kjo.2012.26.6.407350681323204794Search in Google Scholar

[9]Chen Z., Wang L., Stegemann J.P.: Phase-separated chitosanfibrin microbeads for cell delivery. J. Microencapsul., 2011; 28: 344-352 Chen Z. Wang L. Stegemann J.P. Phase-separated chitosanfibrin microbeads for cell delivery J. Microencapsul 2011 28 344 35210.3109/02652048.2011.569764321950821736519Search in Google Scholar

[10]Cheng H., Cao Y., Olson L.: Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science, 1996; 273: 510-513 Cheng H. Cao Y. Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function Science 1996 273 510 51310.1126/science.273.5274.5108662542Search in Google Scholar

[11]Cholewinski E., Dietrich M., Flanagan T.C., Schmitz-Rode T., Jockenhoevel S.: Tranexamic acid-an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng. Part A, 2009; 15: 3645-3653 Cholewinski E. Dietrich M. Flanagan T.C. Schmitz-Rode T. Jockenhoevel S. Tranexamic acid-an alternative to aprotinin in fibrin-based cardiovascular tissue engineering Tissue Eng. Part A 2009 15 3645 365310.1089/ten.tea.2009.023519496679Search in Google Scholar

[12]Christman K.L., Vardanian A.J., Fang Q., Sievers R.E., Fok H.H., Lee R.J.: Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol., 2004; 44: 654-660 Christman K.L. Vardanian A.J. Fang Q. Sievers R.E. Fok H.H. Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium J. Am. Coll. Cardiol 2004 44 654 66010.1016/j.jacc.2004.04.04015358036Search in Google Scholar

[13]Ciardulli M.C., Marino L., Lovecchio J., Giordano E., Forsyth N.R., Selleri C., Ma N., Porta G.: Tendon and cytokine marker expression by human bone marrow mesenchymal stem cells in a hyaluronate/poly-lactic-co-glycolic acid (PLGA)/fibrin three-dimensional (3D) scaffold. Cells, 2020; 9: 1268 Ciardulli M.C. Marino L. Lovecchio J. Giordano E. Forsyth N.R. Selleri C. Ma N. Porta G. Tendon and cytokine marker expression by human bone marrow mesenchymal stem cells in a hyaluronate/poly-lactic-co-glycolic acid (PLGA)/fibrin three-dimensional (3D) scaffold Cells 2020 9 126810.3390/cells9051268729112932443833Search in Google Scholar

[14]Collen A., Smorenburg S., Peters E., Lupu F., Koolwijk P., van Noorden C., van Hinsbergh V.: Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res., 2000; 60: 6196-6200 Collen A. Smorenburg S. Peters E. Lupu F. Koolwijk P. van Noorden C. van Hinsbergh V. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro Cancer Res 2000 60 6196 6200Search in Google Scholar

[15]De Cristofaro R., de Candia E.: Thrombin domains: structure, function and interaction with platelet receptors. J. Thromb. Thrombolysis, 2003; 15: 151-163 De Cristofaro R. de Candia E. Thrombin domains: structure, function and interaction with platelet receptors J. Thromb. Thrombolysis 2003 15 151 16310.1023/B:THRO.0000011370.80989.7bSearch in Google Scholar

[16]Cui X., Boland T.: Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials, 2009; 30: 6221-6227 Cui X. Boland T. Human microvasculature fabrication using thermal inkjet printing technology Biomaterials 2009 30 6221 622710.1016/j.biomaterials.2009.07.05619695697Search in Google Scholar

[17]Cwalina B., Turek A., Nozynski J., Jastrzebska M., Nawrat Z.: Structural changes in pericardium tissue modified with tannic acid. Int. J. Artif. Organs, 2005; 28: 648-653 Cwalina B. Turek A. Nozynski J. Jastrzebska M. Nawrat Z. Structural changes in pericardium tissue modified with tannic acid Int. J. Artif. Organs 2005 28 648 65310.1177/03913988050280061416015575Search in Google Scholar

[18]Dietrich M., Heselhaus J., Wozniak J., Weinandy S., Mela P., Tschoeke B., Schmitz-Rode T., Jockenhoevel S.: Fibrin-based tissue engineering: comparison of different methods of autologous fibrinogen isolation. Tissue Eng. Part C Methods, 2013; 19: 216226 Dietrich M. Heselhaus J. Wozniak J. Weinandy S. Mela P. Tschoeke B. Schmitz-Rode T. Jockenhoevel S. Fibrin-based tissue engineering: comparison of different methods of autologous fibrinogen isolation Tissue Eng. Part C Methods 2013 19 21622610.1089/ten.tec.2011.0473Search in Google Scholar

[19]Drinnan C.T., Zhang G., Alexander M.A., Pulido A.S., Suggs L.J.: Multimodal release of transforming growth factor-β1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels. J. Control. Release, 2010; 147: 180-186 Drinnan C.T. Zhang G. Alexander M.A. Pulido A.S. Suggs L.J. Multimodal release of transforming growth factor-β1 and the BB isoform of platelet derived growth factor from PEGylated fibrin gels J. Control. Release 2010 147 180 18610.1016/j.jconrel.2010.03.02620381553Search in Google Scholar

[20]Ehrbar M., Metters A., Zammaretti P., Hubbell J.A., Zisch A.H.: Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J. Control. Release, 2005; 101: 93-109 Ehrbar M. Metters A. Zammaretti P. Hubbell J.A. Zisch A.H. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity J. Control. Release 2005 101 93 10910.1016/j.jconrel.2004.07.01815588897Search in Google Scholar

[21]Esposito F., Angileri F.F., Kruse P., Cavallo L.M., Solari D., Esposito V., Tomasello F., Cappabianca P.: Fibrin sealants in dura sealing: a systematic literature review. PLoS One, 2016; 11: e0151533 Esposito F. Angileri F.F. Kruse P. Cavallo L.M. Solari D. Esposito V. Tomasello F. Cappabianca P. Fibrin sealants in dura sealing: a systematic literature review PLoS One 2016 11 e015153310.1371/journal.pone.0151533484793327119993Search in Google Scholar

[22]Ferguson J., Nürnberger S., Redl H.: Fibrin: the very first biomimetic glue - still a great tool. W: Biological adhesive systems, red.: J. von Byern, I. Grunwald. Springer Vienna, 2010, 225-236 Ferguson J. Nürnberger S. Redl H. Fibrin: the very first biomimetic glue - still a great tool. W: Biological adhesive systems, red.: J. von Byern, I. Grunwald Springer Vienna 2010 225 23610.1007/978-3-7091-0286-2_15Search in Google Scholar

[23]Freeman S., Ramos R., Chando P.A., Zhou L.: A bioink blend for rotary 3D bioprinting tissue engineered small-diameter vascular constructs. Acta Biomater., 2019; 5: 152-164 Freeman S. Ramos R. Chando P.A. Zhou L. A bioink blend for rotary 3D bioprinting tissue engineered small-diameter vascular constructs Acta Biomater 2019 5 152 16410.1016/j.actbio.2019.06.05231271883Search in Google Scholar

[24]Frey R.: Fibrin sealants. http://www.surgeryencyclopedia.com/Ce-Fi/Fibrin-Sealants.html (06.10.2016) Frey R. Fibrin sealants http://www.surgeryencyclopedia.com/Ce-Fi/Fibrin-Sealants.html (06.10.2016)Search in Google Scholar

[25]Gandossi E., Lunven C., Berry C.N.: Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro. Br. J. Pharmacol., 2000; 129: 1021-1027 Gandossi E. Lunven C. Berry C.N. Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro Br. J. Pharmacol 2000 129 1021 102710.1038/sj.bjp.0703137157192010696104Search in Google Scholar

[26]Gorkun O.V., Veklich Y.I., Medved L.V., Henschen A.H., Weisel J.W.: Role of the .alpha.c domains of fibrin in clot formation. Biochemistry, 1994; 33: 6986-6997 Gorkun O.V. Veklich Y.I. Medved L.V. Henschen A.H. Weisel J.W. Role of the .alpha.c domains of fibrin in clot formation Biochemistry 1994 33 6986 699710.1021/bi00188a0318204632Search in Google Scholar

[27]Goszczyński T., Nevozhay D., Wietrzyk J., Omar M.S., Boratyński J.: The antileukemic activity of modified fibrinogen-methotrexate conjugate. Biochim. Biophys. Acta - Gen. Subj., 2013; 1830: 25262530 Goszczyński T. Nevozhay D. Wietrzyk J. Omar M.S. Boratyński J. The antileukemic activity of modified fibrinogen-methotrexate conjugate Biochim. Biophys. Acta - Gen. Subj 2013 1830 2526253010.1016/j.bbagen.2012.11.00523168301Search in Google Scholar

[28]Gray A., Reeves J., Harrison N., Winlove P., Laurent G.: Growth factors for human fibroblasts in the solute remaining after clot formation. J. Cell. Sci., 1990; 96: 271-274 Gray A. Reeves J. Harrison N. Winlove P. Laurent G. Growth factors for human fibroblasts in the solute remaining after clot formation J. Cell. Sci 1990 96 271 27410.1242/jcs.96.2.2712211868Search in Google Scholar

[29]Gugerell A., Schossleitner K., Wolbank S., Nürnberger S., Redl H., Gulle H., Goppelt A., Bittner M., Pasteiner W.: High thrombin concentrations in fibrin sealants induce apoptosis in human keratinocytes. J. Biomed. Mater. Res. Part A, 2012; 100A: 1239-1247 Gugerell A. Schossleitner K. Wolbank S. Nürnberger S. Redl H. Gulle H. Goppelt A. Bittner M. Pasteiner W. High thrombin concentrations in fibrin sealants induce apoptosis in human keratinocytes. J. Biomed Mater. Res. Part A 2012 100A 1239–124710.1002/jbm.a.3400722359340Search in Google Scholar

[30]Gupta N., Cruz M., Nasser P., Rosenberg J., Iatridis J.: Fibringenipin hydrogel for cartilage tissue engineering in nasal reconstruction. Ann. Otol. Rhinol. Laryngol., 2019; 128: 640-646 Gupta N. Cruz M. Nasser P. Rosenberg J. Iatridis J. Fibringenipin hydrogel for cartilage tissue engineering in nasal reconstruction Ann. Otol. Rhinol. Laryngol 2019 128 640 64610.1177/0003489419836667653848730862177Search in Google Scholar

[31]Harvey S.C.: Fibrin paper as an hæmostatic agent. Ann. Surg., 1918; 68: 66-70 Harvey S.C. Fibrin paper as an hæmostatic agent Ann. Surg 1918 68 66 7010.1097/00000658-191807000-00011142676417863949Search in Google Scholar

[32]Heher P., Mühleder S., Mittermayr R., Redl H., Slezak P.: Fibrin-based delivery strategies for acute and chronic wound healing. Adv. Drug Deliv. Rev., 2018; 129: 134-147 Heher P. Mühleder S. Mittermayr R. Redl H. Slezak P. Fibrin-based delivery strategies for acute and chronic wound healing Adv. Drug Deliv. Rev 2018 129 134 14710.1016/j.addr.2017.12.00729247766Search in Google Scholar

[33]Highlights of prescribing information. https://advancedsurgery.baxter.com/products/tisseel (07.07.2020). Highlights of prescribing information https://advancedsurgery.baxter.com/products/tisseel (07.07.2020)Search in Google Scholar

[34]Hino M., Ishiko O., Honda K., Yamane T., Ohta K., Takubo T., Tatsumi N.: Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br. J. Haematol., 2000; 108: 194-195 Hino M. Ishiko O. Honda K. Yamane T. Ohta K. Takubo T. Tatsumi N. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery Br. J. Haematol 2000 108 194 19510.1046/j.1365-2141.2000.01818.x10651745Search in Google Scholar

[35]Hinton T.J., Jallerat Q., Palchesko R.N., Park J.H., Grodzicki M.S., Shue H.-J., Ramadan M.H., Hudson A.R., Feinberg A.W.: Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels. Sci. Adv., 2015; 1: e1500758 Hinton T.J. Jallerat Q. Palchesko R.N. Park J.H. Grodzicki M.S. Shue H.-J. Ramadan M.H. Hudson A.R. Feinberg A.W. Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels Sci. Adv 2015 1 e150075810.1126/sciadv.1500758Search in Google Scholar

[36]Hirashima M., Imamura T., Yano K., Kawamura R., Meta A., Tokieda Y., Nakashima T.: High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals. J. Bio-chem., 2016; 159: 261-270 Hirashima M. Imamura T. Yano K. Kawamura R. Meta A. Tokieda Y. Nakashima T. High-level expression and preparation of recombinant human fibrinogen as biopharmaceuticals J. Bio-chem 2016 159 261 27010.1093/jb/mvv099Search in Google Scholar

[37]Hojo M., Inokuchi S., Kidokoro M., Fukuyama N., Tanaka E., Tsuji C., Miyasaka M., Tanino R., Nakazawa H.: Induction of vascular endothelial growth factor by fibrin as a dermal substrate for cultured skin substitute. Plast. Reconstr. Surg., 2003; 111: 1638-1646 Hojo M. Inokuchi S. Kidokoro M. Fukuyama N. Tanaka E. Tsuji C. Miyasaka M. Tanino R. Nakazawa H. Induction of vascular endothelial growth factor by fibrin as a dermal substrate for cultured skin substitute Plast. Reconstr. Surg 2003 111 1638 164610.1097/01.PRS.0000053842.90564.26Search in Google Scholar

[38]Jennewein C., Tran N., Paulus P., Ellinghaus P., Eble J.A., Zacharowski K.: Novel aspects of fibrin(ogen) fragments during inflammation. Mol. Med., 2011; 17: 568-573 Jennewein C. Tran N. Paulus P. Ellinghaus P. Eble J.A. Zacharowski K. Novel aspects of fibrin(ogen) fragments during inflammation Mol. Med 2011 17 568 57310.2119/molmed.2010.00146Search in Google Scholar

[39]Joch C.: The safety of fibrin sealants. Cardiovasc. Surg., 2003; 11: 23-28 Joch C. The safety of fibrin sealants Cardiovasc. Surg 2003 11 23 2810.1016/S0967-2109(03)00068-1Search in Google Scholar

[40]Jung R.E., Schmoekel H.G., Zwahlen R., Kokovic V., Hammerle C.H.F., Weber F.E.: Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2. Clin. Oral Implants Res., 2005; 16: 676-682 Jung R.E. Schmoekel H.G. Zwahlen R. Kokovic V. Hammerle C.H.F. Weber F.E. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2 Clin. Oral Implants Res 2005 16 676 68210.1111/j.1600-0501.2005.01183.xSearch in Google Scholar

[41]Kaiser N.J., Kant R.J., Minor A.J., Coulombe K.L.K.: Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes. ACS Biomater. Sci. Eng., 2019; 5: 887-899 Kaiser N.J. Kant R.J. Minor A.J. Coulombe K.L.K. Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes ACS Biomater. Sci. Eng 2019 5 887 89910.1021/acsbiomaterials.8b01112Search in Google Scholar

[42]Kang S.W., Kim J.S., Park K.S., Cha B.H., Shim J.H., Kim J.Y., Cho D.W., Rhie J.W., Lee S.H.: Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone, 2011; 48: 298-306 Kang S.W. Kim J.S. Park K.S. Cha B.H. Shim J.H. Kim J.Y. Cho D.W. Rhie J.W. Lee S.H. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration Bone 2011 48 298 30610.1016/j.bone.2010.09.029Search in Google Scholar

[43]Kawamura M., Sawafuji M., Watanabe M., Horinouchi H., Kobayashi K.: Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann. Thorac. Surg., 2002; 73: 1098-1100 Kawamura M. Sawafuji M. Watanabe M. Horinouchi H. Kobayashi K. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery Ann. Thorac. Surg 2002 73 1098 110010.1016/S0003-4975(02)03415-XSearch in Google Scholar

[44]Kay A., Pepper D., Ewart M.: Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen. Nat. New Biol., 1973; 243: 56-57 Kay A. Pepper D. Ewart M. Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen Nat. New Biol 1973 243 56 57Search in Google Scholar

[45]Lee A.C., Yu V.M., Lowe J.B., Brenner M.J., Hunter D.A., Mack-innon S.E., Sakiyama-Elbert S.E.: Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp. Neurol., 2003; 184: 295-303 Lee A.C. Yu V.M. Lowe J.B. Brenner M.J. Hunter D.A. Mack-innon S.E. Sakiyama-Elbert S.E. Controlled release of nerve growth factor enhances sciatic nerve regeneration Exp. Neurol 2003 184 295 30310.1016/S0014-4886(03)00258-9Search in Google Scholar

[46]Lee J.H., Kang N.Y.: Comparison of fibrin glue and sutures for conjunctival wound closure in strabismus surgery. Korean J. Ophthalmol., 2011; 25: 178-184 Lee J.H. Kang N.Y. Comparison of fibrin glue and sutures for conjunctival wound closure in strabismus surgery Korean J. Ophthalmol 2011 25 178 18410.3341/kjo.2011.25.3.178Search in Google Scholar

[47]Lesman A., Koffler J., Atlas R., Blinder Y.J., Kam Z., Levenberg S.: Engineering vessel-like networks within multicellular fibrinbased constructs. Biomaterials, 2011; 32: 7856-7869 Lesman A. Koffler J. Atlas R. Blinder Y.J. Kam Z. Levenberg S. Engineering vessel-like networks within multicellular fibrinbased constructs Biomaterials 2011 32 7856 786910.1016/j.biomaterials.2011.07.003Search in Google Scholar

[48]Li Y., Meng H., Liu Y., Lee B.P.: Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering. Sci. World J., 2015; 2015: 1-10 Li Y. Meng H. Liu Y. Lee B.P. Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering Sci. World J 2015 2015 1 1010.1155/2015/685690Search in Google Scholar

[49]Lieshout M. Van, Peters G., Rutten M., Baaijens F.: A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng., 2006; 12: 481-487 Lieshout M. Van Peters G. Rutten M. Baaijens F. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve Tissue Eng 2006 12 481 48710.1089/ten.2006.12.481Search in Google Scholar

[50]Lishko V.K., Podolnikova N.P., Yakubenko V.P., Yakovlev S., Medved L., Yadav S.P., Ugarova T.P.: Multiple binding sites in fibrinogen for integrin αMβ2 (Mac-1). J. Biol. Chem., 2004; 279: 44897-44906 Lishko V.K. Podolnikova N.P. Yakubenko V.P. Yakovlev S. Medved L. Yadav S.P. Ugarova T.P. Multiple binding sites in fibrinogen for integrin αMβ2 (Mac-1) J. Biol. Chem 2004 279 44897 4490610.1074/jbc.M408012200Search in Google Scholar

[51]Litvinov R.I., Weisel J.W.: Fibrin mechanical properties and their structural origins. Matrix Biol., 2017; 60-61: 110-123 Litvinov R.I. Weisel J.W. Fibrin mechanical properties and their structural origins Matrix Biol 2017 60-61 110 12310.1016/j.matbio.2016.08.003Search in Google Scholar

[52]Lorand L.: Factor XIII: structure and interactions with fibrinogen and fibrin. Ann. N. Y. Acad. Sci., 2006; 936: 291-311 Lorand L. Factor XIII: structure and interactions with fibrinogen and fibrin Ann. N. Y. Acad. Sci 2006 936 291 31110.1111/j.1749-6632.2001.tb03516.xSearch in Google Scholar

[53]Malafaya P.B., Silva G.A., Reis R.L.: Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev., 2007; 59: 207233 Malafaya P.B. Silva G.A. Reis R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications Adv. Drug Deliv. Rev 2007 59 20723310.1016/j.addr.2007.03.012Search in Google Scholar

[54]Mankad P.S., Codispoti M.: The role of fibrin sealants in hemostasis. Am. J. Surg., 2001; 182: S21-S28 Mankad P.S. Codispoti M. The role of fibrin sealants in hemostasis Am. J. Surg 2001 182 S21 S2810.1016/S0002-9610(01)00773-5Search in Google Scholar

[55]Martino M.M., Briquez P.S., Ranga A., Lutolf M.P., Hubbell J.A.: Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc. Natl. Acad. Sci., 2013; 110: 4563-4568 Martino M.M. Briquez P.S. Ranga A. Lutolf M.P. Hubbell J.A. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix Proc. Natl. Acad. Sci 2013 110 4563 456810.1073/pnas.1221602110360704623487783Search in Google Scholar

[56]Min Sun P., Sang-Soo K., Seung-Woo C., Cha Yong C., Byung-Soo K.: Enhancement of the osteogenic efficacy of osteoblast transplantation by the sustained delivery of basic fibroblast growth factor. J. Biomed. Mater. Res. Part B Appl. Biomater., 2006; 79B: 353-359 Min Sun P. Sang-Soo K. Seung-Woo C. Cha Yong C. Byung-Soo K. Enhancement of the osteogenic efficacy of osteoblast transplantation by the sustained delivery of basic fibroblast growth factor J. Biomed. Mater. Res. Part B Appl. Biomater 2006 79B 353–35910.1002/jbm.b.30549Search in Google Scholar

[57]Mittermayr R., Morton T., Hofmann M., Helgerson S., van Griensven M., Redl H.: Sustained (rh)VEGF 165 release from a sprayed fibrin biomatrix induces angiogenesis, up-regulation of endogenous VEGF-R2, and reduces ischemic flap necrosis. Wound Repair Regen., 2008; 16: 542-550 Mittermayr R. Morton T. Hofmann M. Helgerson S. van Griensven M. Redl H. Sustained (rh)VEGF 165 release from a sprayed fibrin biomatrix induces angiogenesis, up-regulation of endogenous VEGF-R2, and reduces ischemic flap necrosis Wound Repair Regen 2008 16 542 55010.1111/j.1524-475X.2008.00391.xSearch in Google Scholar

[58]Morton T.J., Fürst W., Griensven M. van, Redl H.: Controlled release of substances bound to fibrin-anchors or of DNA. Drug Deliv., 2009; 16: 102-107 Morton T.J. Fürst W. Griensven M. van Redl H. Controlled release of substances bound to fibrin-anchors or of DNA Drug Deliv 2009 16 102 10710.1080/10717540802605608Search in Google Scholar

[59]Narayanan S.: Multifunctional roles of thrombin. Ann. Clin. Lab. Sci., 1999; 29: 275-280 Narayanan S. Multifunctional roles of thrombin Ann. Clin. Lab. Sci 1999 29 275 28010.1086/520197Search in Google Scholar

[60]Noori A., Ashrafi S., Vaez-Ghaemi R., Hatamian-Zaremi A., Webster T.: A review of fibrin and fibrin composites for bone tissue engineering. Int. J. Nanomedicine, 2019; 12: 4937-4961 Noori A. Ashrafi S. Vaez-Ghaemi R. Hatamian-Zaremi A. Webster T. A review of fibrin and fibrin composites for bone tissue engineering Int. J. Nanomedicine 2019 12 4937 496110.2147/IJN.S124671Search in Google Scholar

[61]Osathanon T., Giachelli C.M., Somerman M.J.: Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. Biomaterials, 2009; 30: 4513-4521 Osathanon T. Giachelli C.M. Somerman M.J. Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering Biomaterials 2009 30 4513 452110.1016/j.biomaterials.2009.05.022Search in Google Scholar

[62]Park C., Woo K.: Fibrin-based biomaterial applications in tissue engineering and regenerative medicine. Adv. Exp. Med. Biol., 2018; 1064: 253-261 Park C. Woo K. Fibrin-based biomaterial applications in tissue engineering and regenerative medicine Adv. Exp. Med. Biol 2018 1064 253 26110.1007/978-981-13-0445-3_16Search in Google Scholar

[63]Peyvandi F.: Epidemiology and treatment of congenital fibrinogen deficiency. Thromb. Res., 2012; 130: S7-S11 Peyvandi F. Epidemiology and treatment of congenital fibrinogen deficiency Thromb. Res 2012 130 S7 S1110.1016/S0049-3848(13)70004-5Search in Google Scholar

[64]Rahmany M.B., Hantgan R.R., van Dyke M.: A mechanistic investigation of the effect of keratin-based hemostatic agents on coagulation. Biomaterials, 2013; 34: 2492-2500 Rahmany M.B. Hantgan R.R. van Dyke M. A mechanistic investigation of the effect of keratin-based hemostatic agents on coagulation Biomaterials 2013 34 2492 250010.1016/j.biomaterials.2012.12.00823332318Search in Google Scholar

[65]Ramanathan A., Karuri N.: Fibronectin alters the rate of formation and structure of the fibrin matrix. Biochem. Biophys. Res. Commun., 2014; 443: 395-399 Ramanathan A. Karuri N. Fibronectin alters the rate of formation and structure of the fibrin matrix Biochem. Biophys. Res. Commun 2014 443 395 39910.1016/j.bbrc.2013.11.09024309108Search in Google Scholar

[66]Rao R.R., Peterson A.W., Ceccarelli J., Putnam A.J., Stegemann J.P.: Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis, 2012; 15: 253-264 Rao R.R. Peterson A.W. Ceccarelli J. Putnam A.J. Stegemann J.P. Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials Angiogenesis 2012 15 253 26410.1007/s10456-012-9257-1Search in Google Scholar

[67]Rech J., Wilińska J., Borecka A., Turek A.: Application of fibrin in drug technology: Achievements and perspectives. Postepy Hig. Med. Dosw., 2020; 74: 322-330 Rech J. Wilińska J. Borecka A. Turek A. Application of fibrin in drug technology: Achievements and perspectives Postepy Hig. Med. Dosw 2020 74 322 33010.5604/01.3001.0014.3442Search in Google Scholar

[68]Richardson D.L., Pepper D.S., Kay A.B.: Chemotaxis for human monocytes by fibrinogen-derived peptides. Br. J. Haematol., 1976; 32: 507-514 Richardson D.L. Pepper D.S. Kay A.B. Chemotaxis for human monocytes by fibrinogen-derived peptides Br. J. Haematol 1976 32 507 51410.1111/j.1365-2141.1976.tb00953.xSearch in Google Scholar

[69]Robson S.C., Shephard E.G., Kirsch R.E.: Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1β, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br. J. Haematol., 1994; 86: 322-326 Robson S.C. Shephard E.G. Kirsch R.E. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1β, IL-6 and plasminogen activator inhibitors from monocytes in vitro Br. J. Haematol 1994 86 322 32610.1111/j.1365-2141.1994.tb04733.xSearch in Google Scholar

[70]Sacchi V., Mittermayr R., Hartinger J., Martino M.M., Lorentz K.M., Wolbank S., Hofmann A., Largo R.A., Marschall J.S., Groppa E., Gianni-Barrera R., Ehrbar M., Hubbell J.A., Redl H., Banfi A.: Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc. Natl. Acad. Sci., 2014; 111: 6952-6957 Sacchi V. Mittermayr R. Hartinger J. Martino M.M. Lorentz K.M. Wolbank S. Hofmann A. Largo R.A. Marschall J.S. Groppa E. Gianni-Barrera R. Ehrbar M. Hubbell J.A. Redl H. Banfi A. Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164 Proc. Natl. Acad. Sci 2014 111 6952 695710.1073/pnas.1404605111Search in Google Scholar

[71]Sang-Hyug P., So Ra P., Soo Il C., Ki Soo P., Byoung-Hyun M.: Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Artif. Organs, 2005; 29: 838-845 Sang-Hyug P. So Ra P. Soo Il C. Ki Soo P. Byoung-Hyun M. Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation Artif. Organs 2005 29 838 84510.1111/j.1525-1594.2005.00137.xSearch in Google Scholar

[72]Schense J.C., Bloch J., Aebischer P., Hubbell J.A.: Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nat. Biotechnol., 2000; 18: 415-419 Schense J.C. Bloch J. Aebischer P. Hubbell J.A. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension Nat. Biotechnol 2000 18 415 41910.1038/74473Search in Google Scholar

[73]Schmoekel H., Schense J.C., Weber F.E., Grätz K.W., Gnägi D., Müller R., Hubbell J.A.: Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J. Orthop. Res., 2004; 22: 376-381 Schmoekel H. Schense J.C. Weber F.E. Grätz K.W. Gnägi D. Müller R. Hubbell J.A. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices J. Orthop. Res 2004 22 376 38110.1016/S0736-0266(03)00188-8Search in Google Scholar

[74]Schmoekel H.G., Weber F.E., Schense J.C., Grätz K.W., Schawalder P., Hubbell J.A.: Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol. Bioeng., 2005; 89: 253-262 Schmoekel H.G. Weber F.E. Schense J.C. Grätz K.W. Schawalder P. Hubbell J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices Biotechnol. Bioeng 2005 89 253 26210.1002/bit.2016815619323Search in Google Scholar

[75]Senior R.M., Skogen W.F., Griffin G.L., Wilner G.D.: Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J. Clin. Invest., 1986; 77: 1014-1019 Senior R.M. Skogen W.F. Griffin G.L. Wilner G.D. Effects of fibrinogen derivatives upon the inflammatory response Studies with human fibrinopeptide B. J. Clin. Invest 1986 77 1014 101910.1172/JCI112353Search in Google Scholar

[76]Sierra D.H.: Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J. Biomater. Appl., 1993; 7: 309-352 Sierra D.H. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications J. Biomater. Appl 1993 7 309 35210.1177/0885328293007004028473984Search in Google Scholar

[77]Smadja D.M., Basire A., Amelot A., Conte A., Bièche I., Le Bonniec B.F., Aiach M., Gaussem P.: Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J. Cell. Mol. Med., 2008; 12: 975-986 Smadja D.M. Basire A. Amelot A. Conte A. Bièche I. Le Bonniec B.F. Aiach M. Gaussem P. Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells J. Cell. Mol. Med 2008 12 975 98610.1111/j.1582-4934.2008.00161.x440113618494938Search in Google Scholar

[78]Spicer P.P., Mikos A.G.: Fibrin glue as a drug delivery system. J. Control. Release, 2010; 148: 49-55 Spicer P.P. Mikos A.G. Fibrin glue as a drug delivery system J. Control. Release 2010 148 49 5510.1016/j.jconrel.2010.06.025300554620637815Search in Google Scholar

[79]Spotnitz W.D.: Fibrin sealant: the only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective. ISRN Surg., 2014; 2014: 1-28 Spotnitz W.D. Fibrin sealant: the only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective ISRN Surg 2014 2014 1 2810.1155/2014/203943396074624729902Search in Google Scholar

[80]Sreerekha P.R., Menon D., Nair S. V., Chennazhi K.P.: Fabrication of fibrin based electrospun multiscale composite scaffold for tissue engineering applications. J. Biomed. Nanotechnol., 2013; 9: 790-800 Sreerekha P.R. Menon D. Nair S. V. Chennazhi K.P. Fabrication of fibrin based electrospun multiscale composite scaffold for tissue engineering applications J. Biomed. Nanotechnol 2013 9 790 80010.1166/jbn.2013.158523802408Search in Google Scholar

[81]Taylor S.J., Rosenzweig E.S., McDonald J.W., Sakiyama-Elbert S.E.: Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J. Control. Release, 2006; 113: 226-235 Taylor S.J. Rosenzweig E.S. McDonald J.W. Sakiyama-Elbert S.E. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury J. Control. Release 2006 113 226 23510.1016/j.jconrel.2006.05.005161596716797770Search in Google Scholar

[82]Thompson W.D., Smith E.B., Stirk C.M., Marshall F.I., Stout A.J., Kocchar A.: Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J. Pathol., 1992; 168: 47-53 Thompson W.D. Smith E.B. Stirk C.M. Marshall F.I. Stout A.J. Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E J. Pathol 1992 168 47 5310.1002/path.17116801091280677Search in Google Scholar

[83]Tidrick R.T., Warner E.D.: Fibrin fixation of skin transplants. Surgery, 1944; 15: 90-95 Tidrick R.T. Warner E.D. Fibrin fixation of skin transplants Surgery 1944 15 90 95Search in Google Scholar

[84]Turek A., Stoklosa K., Borecka A., Paul-Samojedny M., Kaczmarczyk B., Marcinkowski A., Kasperczyk J.: Designing biodegradable wafers based on poly(L-lactide-co-glycolide) and poly(glycolideco-ε-caprolactone) for the prolonged and local release of idarubicin for the therapy of glioblastoma multiforme. Pharm. Res., 2020; 37: 90 Turek A. Stoklosa K. Borecka A. Paul-Samojedny M. Kaczmarczyk B. Marcinkowski A. Kasperczyk J. Designing biodegradable wafers based on poly(L-lactide-co-glycolide) and poly(glycolideco-ε-caprolactone) for the prolonged and local release of idarubicin for the therapy of glioblastoma multiforme Pharm. Res 2020 37 9010.1007/s11095-020-02810-2720578132382838Search in Google Scholar

[85]Turek A., Cwalina B., Kobielarz M.: Radioisotopic investigation of crosslinking density in bovine pericardium used as a biomaterial. Nukleonika, 2013; 58: 511-517 Turek A. Cwalina B. Kobielarz M. Radioisotopic investigation of crosslinking density in bovine pericardium used as a biomaterial Nukleonika 2013 58 511 517Search in Google Scholar

[86]Turek A., Wilińska J., Borecka A., Pawlus-Łachecka L.: Application of antibiotics in the sterilization of homogeneic heart valves. Postepy Hig. Med. Dosw., 2017; 71: 1187-1201 Turek A. Wilińska J. Borecka A. Pawlus-Łachecka L. Application of antibiotics in the sterilization of homogeneic heart valves Postepy Hig. Med. Dosw 2017 71 1187 120110.5604/01.3001.0010.7669Search in Google Scholar

[87]VeraSeal: EPAR – Product Information. https://www.ema.europa.eu/en/medicines/human/EPAR/veraseal-0#product-information-section (07.07.2020) VeraSeal EPAR – Product Information https://www.ema.europa.eu/en/medicines/human/EPAR/veraseal-0#product-information-section (07.07.2020)Search in Google Scholar

[88]Verma K., Errico T.J., Vaz K.M., Lonner B.S.: A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. BMC Surg., 2010; 10: 13 Verma K. Errico T.J. Vaz K.M. Lonner B.S. A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery BMC Surg 2010 10 1310.1186/1471-2482-10-13285812920370916Search in Google Scholar

[89]Voge C.M., Johns J., Raghavan M., Morris M.D., Stegemann J.P.: Wrapping and dispersion of multiwalled carbon nanotubes improves electrical conductivity of protein-nanotube composite biomaterials. J. Biomed. Mater. Res. Part A, 2013; 101A: 231-238 Voge C.M. Johns J. Raghavan M. Morris M.D. Stegemann J.P. Wrapping and dispersion of multiwalled carbon nanotubes improves electrical conductivity of protein-nanotube composite biomaterials J. Biomed. Mater. Res. Part A 2013 101A 231–23810.1002/jbm.a.3431022865813Search in Google Scholar

[90]Wang X., Sui S., Yan Y., Zhang R.: Design and fabrication of PLGA sandwiched cell/fibrin constructs for complex organ regeneration. J. Bioact. Compat. Polym., 2010; 25: 229-240 Wang X. Sui S. Yan Y. Zhang R. Design and fabrication of PLGA sandwiched cell/fibrin constructs for complex organ regeneration J. Bioact. Compat. Polym 2010 25 229 24010.1177/0883911510365661Search in Google Scholar

[91]Wardrop D., Estcourt L.J., Brunskill S.J., Doree C., Trivella M., Stanworth S., Murphy M.F.: Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database Syst. Rev., 2016; 3: CD009733 Wardrop D. Estcourt L.J. Brunskill S.J. Doree C. Trivella M. Stanworth S. Murphy M.F. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders Cochrane Database Syst. Rev 2016 3 CD00973310.1002/14651858.CD009733.pub223897323Search in Google Scholar

[92]Weisel J.W., Litvinov R.I.: Fibrin formation, structure and properties. Subcell Biochem., 2017; 82: 405-456 Weisel J.W. Litvinov R.I. Fibrin formation, structure and properties Subcell Biochem 2017 82 405 45610.1007/978-3-319-49674-0_13553612028101869Search in Google Scholar

[93]Weisel J.W., Medved L.: The structure and function of the αC domains of fibrinogen. Ann. N. Y. Acad. Sci., 2006; 936: 312-327 Weisel J.W. Medved L. The structure and function of the αC domains of fibrinogen Ann. N. Y. Acad. Sci 2006 936 312 32710.1111/j.1749-6632.2001.tb03517.x11460487Search in Google Scholar

[94]Wilińska J., Turek A., Borecka A., Rech J., Kasperczyk J.: Electron beam sterilization of implantable rods with risperidone and with 17-β-estradiol: A structural, thermal and morphology study. Acta Bioeng. Biomech., 2019; 21: 39-47 Wilińska J. Turek A. Borecka A. Rech J. Kasperczyk J. Electron beam sterilization of implantable rods with risperidone and with 17-β-estradiol: A structural, thermal and morphology study Acta Bioeng. Biomech 2019 21 39 47Search in Google Scholar

[95]Willerth S.M., Rader A., Sakiyama-Elbert S.E.: The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res., 2008; 1: 205-218 Willerth S.M. Rader A. Sakiyama-Elbert S.E. The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds Stem Cell Res 2008 1 205 21810.1016/j.scr.2008.05.006274494619383401Search in Google Scholar

[96]Wnek G.E., Carr M.E., Simpson D.G., Bowlin G.L.: Electrospinning of nanofiber fibrinogen structures. Nano Lett., 2003; 3: 213216 Wnek G.E. Carr M.E. Simpson D.G. Bowlin G.L. Electrospinning of nanofiber fibrinogen structures Nano Lett 2003 3 21321610.1021/nl025866cSearch in Google Scholar

[97]Wood M.D., Borschel G.H., Sakiyama-Elbert S.E.: Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J. Biomed. Mater. Res. Part A, 2009; 89A: 909-918 Wood M.D. Borschel G.H. Sakiyama-Elbert S.E. Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J. Biomed Mater. Res. Part A 2009 89A 909 91810.1002/jbm.a.3204318465825Search in Google Scholar

[98]Wysocka A., Mann K., Bursig H., Dec J., Gaździk T.S.: Chondrocyte suspension in fibrin glue. Cell Tissue Bank., 2010; 11: 209215 Wysocka A. Mann K. Bursig H. Dec J. Gaździk T.S. Chondrocyte suspension in fibrin glue Cell Tissue Bank 2010 11 20921510.1007/s10561-009-9163-y20390360Search in Google Scholar

[99]Xu M., Wang X., Yan Y., Yao R., Ge Y.: An cell-assembly derived physiological 3D model of the metabolic syndrome, based on adipose-derived stromal cells and a gelatin/alginate/fibrinogen matrix. Biomaterials, 2010; 31: 3868-3877 Xu M. Wang X. Yan Y. Yao R. Ge Y. An cell-assembly derived physiological 3D model of the metabolic syndrome, based on adipose-derived stromal cells and a gelatin/alginate/fibrinogen matrix Biomaterials 2010 31 3868 387710.1016/j.biomaterials.2010.01.11120153520Search in Google Scholar

[100]Xu W., Wang X., Yan Y., Zheng W., Xiong Z., Lin F., Wu R., Zhang R.: Rapid prototyping three-dimensional cell/gelatin/fibrinogen constructs for medical regeneration. J. Bioact. Compat. Polym., 2007; 22: 363-377 Xu W. Wang X. Yan Y. Zheng W. Xiong Z. Lin F. Wu R. Zhang R. Rapid prototyping three-dimensional cell/gelatin/fibrinogen constructs for medical regeneration J. Bioact. Compat. Polym 2007 22 363 37710.1177/0883911507079451Search in Google Scholar

[101]Ye Q., Zünd G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., Hubbell J.A., Turina M.: Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardio-Thoracic Surg., 2000; 17: 587-591 Ye Q. Zünd G. Benedikt P. Jockenhoevel S. Hoerstrup S.P. Sakyama S. Hubbell J.A. Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering Eur. J. Cardio-Thoracic Surg 2000 17 587 59110.1016/S1010-7940(00)00373-0Search in Google Scholar

[102]Zhang G., Nakamura Y., Wang X., Hu Q., Suggs L.J., Zhang J.: Controlled release of stromal cell-derived factor-1alpha in situ increases C-kit + cell homing to the infarcted heart. Tissue Eng., 2007; 13: 2063-2071 Zhang G. Nakamura Y. Wang X. Hu Q. Suggs L.J. Zhang J. Controlled release of stromal cell-derived factor-1alpha in situ increases C-kit + cell homing to the infarcted heart Tissue Eng 2007 13 2063 207110.1089/ten.2006.001317518719Search in Google Scholar

[103]Zhang L., Zhang L., Lan X., Xu M., Mao Z., Lv H., Yao Q., Tang P.: Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures. J. Mater. Sci. Mater. Med., 2014; 25: 1165-1172 Zhang L. Zhang L. Lan X. Xu M. Mao Z. Lv H. Yao Q. Tang P. Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures J. Mater. Sci. Mater. Med 2014 25 1165 117210.1007/s10856-013-5138-424435526Search in Google Scholar

[104]Zhao W., Han Q., Lin H., Sun W., Gao Y., Zhao Y., Wang B., Wang X., Chen B., Xiao Z., Dai J.: Human basic fibroblast growth factor fused with Kringle4 peptide binds to a fibrin scaffold and enhances angiogenesis. Tissue Eng. Part A, 2009; 15: 991-998 Zhao W. Han Q. Lin H. Sun W. Gao Y. Zhao Y. Wang B. Wang X. Chen B. Xiao Z. Dai J. Human basic fibroblast growth factor fused with Kringle4 peptide binds to a fibrin scaffold and enhances angiogenesis Tissue Eng. Part A 2009 15 991 99810.1089/ten.tea.2008.024018771415Search in Google Scholar

[105]Zhu S.-J., Choi B.-H., Jung J.-H., Lee S.-H., Huh J.-Y., You T.-M., Lee H.-J., Li J.: A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 2006; 102: 175-179 Zhu S.-J. Choi B.-H. Jung J.-H. Lee S.-H. Huh J.-Y. You T.-M. Lee H.-J. Li J. A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod 2006 102 175 17910.1016/j.tripleo.2005.08.03416876059Search in Google Scholar